首页|妊娠糖尿病应用门冬胰岛素、地特胰岛素联合治疗的有效性及安全性探讨

妊娠糖尿病应用门冬胰岛素、地特胰岛素联合治疗的有效性及安全性探讨

Efficacy and Safety of Combined Treatment of Insulin Aspartate and Insu-lin Detemir in Gestational Diabetes Mellitus

扫码查看
目的 研究门冬胰岛素、地特胰岛素联合治疗妊娠糖尿病的效果.方法 选取2020年1月—2023年12月泰州市第二人民医院收治的 112例妊娠糖尿病患者为研究对象,以随机数表法分对照组和观察组,各56例.对照组应用门冬胰岛素治疗,观察组在对照组基础上联合地特胰岛素治疗,比较两组血糖水平、不良反应发生情况及妊娠结局.结果 治疗后,观察组空腹血糖、餐后2 h血糖、糖化血红蛋白分别为(5.30±0.42)mmol/L、(6.13±0.60)mmol/L、(5.10±0.17)%,均低于对照组,差异有统计学意义(t=13.186、12.466、11.502,P均<0.05).观察组剖宫产率、围生儿不良结局发生率分别为10.71%、8.93%,均低于对照组,差异有统计学意义(χ2=5.657、4.236,P均<0.05).两组不良反应总发生率比较(5.36%vs 10.71%),差异无统计学意义(χ2=1.087,P>0.05).结论 对妊娠糖尿病患者进行门冬胰岛素联合地特胰岛素治疗可更好地控制血糖水平,获得良好的妊娠结局,同时具有良好的安全性.
Objective To study the effect of the combined treatment of insulin aspartate and insulin detemir on gesta-tional diabetes mellitus.Methods A total of 112 patients with gestational diabetes mellitus treated in Taizhou Second People's Hospital from January 2020 to December 2023 were selected as the study objects and divided into control group and observation group by random number table method,with 56 cases in each group.The control group was treated with insulin aspartate,and the observation group was treated with combination of insulin detemir on the basis of the control group.Blood glucose levels,adverse reactions and pregnancy outcomes were compared between the two groups.Results After treatment,the fasting blood glucose,2-hour postprandial plasma glucose,and glycated hemoglo-bin in the observation group were(5.30±0.42)mmol/L,(6.13±0.60)mmol/L,and(5.10±0.17)%,respectively,which were lower than those in the control group,and the differences were statistically significant(t=13.186,12.466,11.502,all P<0.05).The rates of cesarean section and perinatal adverse outcomes in the observation group were 10.71%and 8.93%,respectively,lower than those in the control group,and the differences were statistically significant(χ2=5.657,4.236,both P<0.05).There was no statistically significant difference in the total incidence of adverse reactions(5.36%vs 10.71%)between the two groups(χ2=1.087,P>0.05).Conclusion The combination of insulin aspartate and insulin detemir in patients with gestational diabetes can better control blood glucose levels,achieve good pregnancy outcomes,and have good safety.

Gestational diabetes mellitusInsulin aspartateInsulin detemirEffectivenessSecurity

吴建云、姜小华、申翠

展开 >

泰州市第二人民医院产科,江苏泰州 225500

妊娠糖尿病 门冬胰岛素 地特胰岛素 有效性 安全性

2024

糖尿病新世界
中国病理生理学会

糖尿病新世界

影响因子:0.461
ISSN:1672-4062
年,卷(期):2024.27(6)
  • 18